Skip Navigation
Skip to contents

ASNO


News

[ASNO 2024] Presenting Distinguished International Speakers at ASNO Annual Meeting 2024

  • ASNO
  • 2024-06-11
  • Hit 1,042
ASNO 2024 | Presenting Distinguished International Speakers at ASNO Annual Meeting 2024

www.ssno.sg/asno2024

Presenting Distinguished International Speakers at ASNO Annual Meeting 2024

Discover an extraordinary gathering of esteemed global thought leaders in neuro-oncology at the highly anticipated ASNO Annual Meeting 2024.

Eric Leuthardt - USA

Chief, Division of Neurotechnology
Washington University School of Medicine

Topic: The Application of LITT in Glioma Treatment

Hai Yan - Singapore

NeuroPhenomics
Agency for Science, Technology and

Research (ASTAR)
Topic: Biologic and Therapeutic Roles of

IDH Mutation

 

Hugues Duffau - France

Professor and Chairman of the

Neurosurgery Department
Montpellier University Medical Center

Topic: Awake Craniotomy for Low Grade Glioma

Li Wei Zhang - China

Director of Neurosurgery Department and

Vice President
Beijing Tiantan Hospital

Topic: Brainstem Glioma Immunotherapy Trial

 

Matthias Preusser - Austria

Professor of Medical Oncology and

Head Clinical Division of Oncology
Department of Medicine I
Medical University of Vienna

Topic: New Advances in Treatment of Breast Cancer with Brain Metastases

Nathalie Albert - Germany

Senior Physician and

Professor for Nuclear Medicine
Ludwig Maximilian University of Munich

Topic 1: Clinical Use of PET Imaging in Glioblastoma
Topic 2: PET Imaging in Patients with

Brain Metastases

 

Rakesh Jalali - India
Medical Director and Lead Neuro-Oncology Apollo Proton Cancer Centre, Chennai,

Tamil Nadu
Topic: Precision Radiotherapy Approaches for Minimizing Toxicity in Low Grade Gliomas

Susan Chang - USA

Director, Division of Neuro-Oncology
UCSF Brain Tumor Center

Topic: Glioblastoma Clinical Trials and

RANO 2.0

View Full Programme

*We will be featuring our speakers regularly in future mailers.

The 19th ASNO Annual Meeting is a must-attend event due to its comprehensive coverage of cutting-edge topics in neuro-oncology. The sessions will delve into crucial topics such as IDH – Mutant Low Grade Glioma,  Glioblastoma -  IDH Wild Type, providing invaluable insights into tumour surgery, current practices, and future trends over the next 20 years. You'll gain a deep understanding of cutting-edge neuro-oncology practices in Asia, including advancements in radiation oncology, survivorship, nursing care, and the management of brain/spine metastases. Additionally, the conference will cover the importance of multidisciplinary care, pediatric neuro-oncology, and patient advocacy, making it an indispensable learning adventure for anyone in this field.

4

 

10

 

42

Plenary

Sessions

 

Concurrent Sessions

 

International Speakers

 

We are extending the early bird rate deadline to 14 June 2024! Don’t miss this chance to register at a special rate.

Register Now

Connect with us on LinkedIn for more updates on the exciting programme:

Contact us

www.ssno.sg/asno2024

TOP


ASNO Central Office: c/o The Plan Co.
3F, JUNG E&C Bldg., 31-5, Seocho-daero 58-gil, Seocho-gu, Seoul 06632 Korea
아시아신경종양학회
  • 사업자등록번호: 108-82-82942
  • 대표자: 김세혁
  • 연락처: 02-538-2042~3
주소: 서울특별시 서초구 서초대로 350, 4층 407호 (서초동, 서초동 동아빌라트)

Copyright © ASNO (Asian Society for Neuro-Oncology) 2022. All rights reserved.